Literature DB >> 10831801

Changes in the development of experimental autoimmune prostatitis (EAP) by castration in aged rats.

G Morón1, B Maletto, A Rópolo, M C Pistoresi-Palencia.   

Abstract

During Experimental Autoimmune Prostatitis (EAP), 12-month-old rats show a higher cellular autoimmune response and lower humoral autoimmune response against prostatic components than 3-month-old rats subjected to the same antigen stimulus. We analyzed if thymus recovery by orchidectomy could affect the development of EAP in 12-month-old rats. Thirty days after gonadectomy, 12-month-old rats showed an increment in the thymic mass and in the thymocytes absolute number, with percentages of the four main cell subpopulations (defined by CD4-CD8 molecules expression) similar to the 3-month-old rats. The DTH response of castrated 12-month-old with EAP were diminished in comparison with sham-castrated 12-month-old rats with EAP, resembling the values observed in 3-month-old rats with EAP. The prostates of castrated 12-month-old rats with EAP did not show inflammatory mononuclear cell infiltration, as did control 3- and 12-month-old rats with EAP. Castration seems to modulate negatively EAP in 12-month-old rats, possibly through the regeneration of thymus after testosterone deprivation.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10831801     DOI: 10.1016/s0145-305x(99)00088-9

Source DB:  PubMed          Journal:  Dev Comp Immunol        ISSN: 0145-305X            Impact factor:   3.636


  4 in total

Review 1.  Acute urinary retention in men: the risks and outcomes with medical therapy.

Authors:  Timothy B Hargreave; Alan S McNeill
Journal:  Curr Urol Rep       Date:  2005-07       Impact factor: 2.862

Review 2.  Prostatitis versus pelvic pain syndrome: immunologic studies.

Authors:  Caroline Maake; Hubert John
Journal:  Curr Urol Rep       Date:  2003-08       Impact factor: 2.862

Review 3.  Theories of prostatitis etiology.

Authors:  Matthew E Karlovsky; Michel A Pontari
Journal:  Curr Urol Rep       Date:  2002-08       Impact factor: 2.862

4.  New therapy with ASC-J9® to suppress the prostatitis via altering the cytokine CCL2 signals.

Authors:  Shin-Jen Lin; Fu-Ju Chou; Chang-Yi Lin; Hong-Chiang Chang; Shuyuan Yeh; Chawnshang Chang
Journal:  Oncotarget       Date:  2016-10-11
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.